166480 — Corestemchemon Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Market Cap
KR₩85bn
Enterprise Value
KR₩128bn
Revenue
KR₩29bn

Annual balance sheet for Corestemchemon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	93,486	68,748	2,592	2,707	3,489
Net Total Accounts Receivable
Net Total Receivables	7,254	6,711	11,184	6,741	10,126
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	101,760	76,522	15,206	10,721	15,784
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	32,039	44,927	50,144	55,722	90,087
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	142,871	136,408	77,054	78,591	117,457
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	68,691	62,162	27,872	41,592	41,932
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	101,585	99,218	38,420	58,991	68,864
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	41,286	37,191	38,634	19,601	48,593
Total Liabilities & Shareholders' Equity	142,871	136,408	77,054	78,591	117,457
Total Common Shares Outstanding